Osimertinib for Advanced EGFR-positive NSCLC Patients

NCT05037331 · clinicaltrials.gov ↗

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

EGFR Positive Non-small Cell Lung Cancer
Non Small Cell Lung Cancer

Sponsor

National University Hospital, Singapore